Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Advances in managing the noninfected open chest after cardiac surgery: Negative-pressure wound therapy.

Bakaeen FG, Haddad O, Ibrahim M, Pasadyn SR, Germano E, Mok S, Halbreiner MS, McCurry KR, Johnston DR, Mick SL, Navia JL, Roselli EE, Smedira NG, Soltesz EG, Tong MZ, Wierup P, Gillinov AM, Svensson LG, Houghtaling PL, Blackstone EH, Pettersson GB.

J Thorac Cardiovasc Surg. 2019 May;157(5):1891-1903.e9. doi: 10.1016/j.jtcvs.2018.10.152. Epub 2018 Nov 27.

PMID:
30709676
2.

Mitral Valve Endocarditis: A Rare Manifestation of Lyme Disease.

Haddad O, Gillinov M, Fraser T, Shrestha N, Pettersson GB.

Ann Thorac Surg. 2019 Aug;108(2):e85-e86. doi: 10.1016/j.athoracsur.2018.12.046. Epub 2019 Jan 25.

PMID:
30690018
3.

Comparative study of virulence factors among methicillin resistant Staphylococcus aureus clinical isolates.

Haddad O, Merghni A, Elargoubi A, Rhim H, Kadri Y, Mastouri M.

BMC Infect Dis. 2018 Nov 13;18(1):560. doi: 10.1186/s12879-018-3457-2.

4.

Chronic ischemic mitral valve regurgitation and surgical perspectives.

Altarabsheh SE, Deo SV, Rababa'h A, Obeidat YM, Haddad O.

World J Cardiol. 2018 Oct 26;10(10):141-144. doi: 10.4330/wjc.v10.i10.141. Review.

5.

Chromobacterium violaceum and Pseudomonas aeruginosa PAO1: Models for Evaluating Anti-Quorum Sensing Activity of Melaleuca alternifolia Essential Oil and Its Main Component Terpinen-4-ol.

Noumi E, Merghni A, M Alreshidi M, Haddad O, Akmadar G, De Martino L, Mastouri M, Ceylan O, Snoussi M, Al-Sieni A, De Feo V.

Molecules. 2018 Oct 17;23(10). pii: E2672. doi: 10.3390/molecules23102672.

6.

Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses.

Marinval N, Morenc M, Labour MN, Samotus A, Mzyk A, Ollivier V, Maire M, Jesse K, Bassand K, Niemiec-Cyganek A, Haddad O, Jacob MP, Chaubet F, Charnaux N, Wilczek P, Hlawaty H.

Biomaterials. 2018 Jul;172:14-29. doi: 10.1016/j.biomaterials.2018.01.054. Epub 2018 Mar 16.

PMID:
29715592
7.

Lessons about Causes and Management of an Ebola Outbreak.

Elargoubi A, Khelifa AWB, Haddad O, Mhalla S, Sakly N, Mastouri M.

Folia Med (Plovdiv). 2017 Dec 20;59(4):387-395. doi: 10.1515/folmed-2017-0032. Review.

PMID:
29341945
8.

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.

Suffee N, Le Visage C, Hlawaty H, Aid-Launais R, Vanneaux V, Larghero J, Haddad O, Oudar O, Charnaux N, Sutton A.

Sci Rep. 2017 Oct 16;7(1):13294. doi: 10.1038/s41598-017-13444-7.

9.

Continuous-flow, implantable biventricular assist device as bridge to cardiac transplantation in a small child with restrictive cardiomyopathy.

Glass L, Savage A, Haddad O, Kavarana MN.

J Heart Lung Transplant. 2018 Jan;37(1):173-174. doi: 10.1016/j.healun.2017.08.001. Epub 2017 Aug 10. No abstract available.

PMID:
28843949
10.

NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation.

Rolas L, Boussif A, Weiss E, Lettéron P, Haddad O, El-Benna J, Rautou PE, Moreau R, Périanin A.

Gut. 2018 Aug;67(8):1505-1516. doi: 10.1136/gutjnl-2016-313443. Epub 2017 Jun 10.

PMID:
28601846
11.

Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.

Marinval N, Saboural P, Haddad O, Maire M, Bassand K, Geinguenaud F, Djaker N, Ben Akrout K, Lamy de la Chapelle M, Robert R, Oudar O, Guyot E, Laguillier-Morizot C, Sutton A, Chauvierre C, Chaubet F, Charnaux N, Hlawaty H.

Mar Drugs. 2016 Oct 17;14(10). pii: E185.

12.

Hawthorn Herb Increases the Risk of Bleeding after Cardiac Surgery: An Evidence-Based Approach.

Rababa'h AM, Altarabsheh SE, Haddad O, Deo SV, Obeidat Y, Al-Azzam S.

Heart Surg Forum. 2016 Aug 22;19(4):E175-9. doi: 10.1532/hsf.1570.

PMID:
27585196
13.

Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).

van de Donk NW, Otten HG, El Haddad O, Axel A, Sasser AK, Croockewit S, Jacobs JF.

Clin Chem Lab Med. 2016 Jun 1;54(6):1105-9. doi: 10.1515/cclm-2015-0888.

PMID:
26812873
14.

A Successful Endovascular Treatment of an Ischemic Stroke following Cardiac Surgery.

Al-Khawaldeh MA, Haddad OK, Alshabatat AO, Deo SV, Rababa'h A, Altarabsheh SE.

Oman Med J. 2015 Nov;30(6):473-6. doi: 10.5001/omj.2015.92.

15.

Epidemiological and biomechanical evaluation of airline baggage handling.

Tafazzol A, Aref S, Mardani M, Haddad O, Parnianpour M.

Int J Occup Saf Ergon. 2016;22(2):218-27. doi: 10.1080/10803548.2015.1126457. Epub 2016 Mar 23.

PMID:
26654282
16.

Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-Morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H.

Mar Drugs. 2015 Oct 28;13(11):6588-608. doi: 10.3390/md13116588.

17.

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress.

Mondadori dos Santos A, Metzinger L, Haddad O, M'baya-Moutoula E, Taïbi F, Charnaux N, Massy ZA, Hlawaty H, Metzinger-Le Meuth V.

Biomed Res Int. 2015;2015:497280. doi: 10.1155/2015/497280. Epub 2015 Jun 28.

18.

Coronary Artery Bypass Grafting After Percutaneous Intervention Has Higher Early Mortality: A Meta-Analysis.

Altarabsheh SE, Deo SV, Hang D, Haddad OK, Cho YH, Markowitz AH, Park SJ.

Ann Thorac Surg. 2015 Jun;99(6):2046-52. doi: 10.1016/j.athoracsur.2014.12.073. Epub 2015 Apr 9. Review.

PMID:
25865763
19.

Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice.

Purnama A, Aid-Launais R, Haddad O, Maire M, Mantovani D, Letourneur D, Hlawaty H, Le Visage C.

Drug Deliv Transl Res. 2015 Apr;5(2):187-97. doi: 10.1007/s13346-013-0177-4.

PMID:
25787743
20.

RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Maillard L, Saito N, Hlawaty H, Friand V, Suffee N, Chmilewsky F, Haddad O, Laguillier C, Guyot E, Ueyama T, Oudar O, Sutton A, Charnaux N.

Biol Open. 2014 Sep 26;3(10):995-1004. doi: 10.1242/bio.20148227.

21.

Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus.

Suzuki M, Bachelet-Violette L, Rouzet F, Beilvert A, Autret G, Maire M, Menager C, Louedec L, Choqueux C, Saboural P, Haddad O, Chauvierre C, Chaubet F, Michel JB, Serfaty JM, Letourneur D.

Nanomedicine (Lond). 2015 Jan;10(1):73-87. doi: 10.2217/nnm.14.51. Epub 2014 Jun 24.

22.

Abdominal aortic aneurysms targeted by functionalized polysaccharide microparticles: a new tool for SPECT imaging.

Bonnard T, Yang G, Petiet A, Ollivier V, Haddad O, Arnaud D, Louedec L, Bachelet-Violette L, Derkaoui SM, Letourneur D, Chauvierre C, Le Visage C.

Theranostics. 2014 Mar 11;4(6):592-603. doi: 10.7150/thno.7757. eCollection 2014.

23.

Optimized multimodal nanoplatforms for targeting α(v)β3 integrins.

Bolley J, Lalatonne Y, Haddad O, Letourneur D, Soussan M, Pérard-Viret J, Motte L.

Nanoscale. 2013 Dec 7;5(23):11478-89. doi: 10.1039/c3nr03763k.

PMID:
24154564
24.

New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation.

Delcombel R, Janssen L, Vassy R, Gammons M, Haddad O, Richard B, Letourneur D, Bates D, Hendricks C, Waltenberger J, Starzec A, Sounni NE, Noël A, Deroanne C, Lambert C, Colige A.

Angiogenesis. 2013 Apr;16(2):353-71. doi: 10.1007/s10456-012-9320-y. Epub 2012 Dec 20.

PMID:
23254820
25.

Trapezius muscle activity in using ordinary and ergonomically designed dentistry chairs.

Haddad O, Sanjari MA, Amirfazli A, Narimani R, Parnianpour M.

Int J Occup Environ Med. 2012 Apr;3(2):76-83.

26.

RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.

Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A.

Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.

PMID:
22752444
27.

HBMO algorithm for calibrating water distribution network of Langarud city.

Sabbaghpour S, Naghashzadehgan M, Javaherdeh K, Haddad OB.

Water Sci Technol. 2012;65(9):1564-9. doi: 10.2166/wst.2012.045.

PMID:
22508117
28.

Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.

Briane D, Slimani H, Tagounits A, Naejus R, Haddad O, Coudert R, Charnaux N, Cao A.

J Drug Target. 2012 May;20(4):347-54. doi: 10.3109/1061186X.2012.656645.

PMID:
22475204
29.

The mechanical behavior of mutant K14-R125P keratin bundles and networks in NEB-1 keratinocytes.

Beriault DR, Haddad O, McCuaig JV, Robinson ZJ, Russell D, Lane EB, Fudge DS.

PLoS One. 2012;7(2):e31320. doi: 10.1371/journal.pone.0031320. Epub 2012 Feb 21.

30.

TIEG1-null tenocytes display age-dependent differences in their gene expression, adhesion, spreading and proliferation properties.

Haddad O, Gumez L, Hawse JR, Subramaniam M, Spelsberg TC, Bensamoun SF.

Exp Cell Res. 2011 Jul 15;317(12):1726-35. doi: 10.1016/j.yexcr.2011.05.007. Epub 2011 May 18.

31.

Study of adiponectin in chronic liver disease and cholestasis.

Salman TA, Allam N, Azab GI, Shaarawy AA, Hassouna MM, El-Haddad OM.

Hepatol Int. 2010 Oct 9;4(4):767-74. doi: 10.1007/s12072-010-9216-0.

32.

Systemic lupus erythematosus in the elderly.

Achour A, Mankaï A, Thabet Y, Sakly W, Braham F, Kechrid C, Bahri F, Bouajina E, Chouchène S, Haddad O, Ghedira I.

Rheumatol Int. 2012 May;32(5):1225-9. doi: 10.1007/s00296-010-1744-3. Epub 2011 Jan 22.

PMID:
21258803
33.

Influence of asymmetry on the flexion relaxation response of the low back musculature.

Ning X, Haddad O, Jin S, Mirka GA.

Clin Biomech (Bristol, Avon). 2011 Jan;26(1):35-9. doi: 10.1016/j.clinbiomech.2010.08.012. Epub 2010 Oct 12.

PMID:
20943296
34.

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V, Laguillier-Morizot C, Gattegno L, Letourneur D, Charnaux N.

Biochem Pharmacol. 2011 Jan 15;81(2):233-43. doi: 10.1016/j.bcp.2010.09.021. Epub 2010 Sep 29.

PMID:
20887714
35.

Hand-hold location and trunk kinematics during box handling.

Haddad O, Mirka GA.

Ergonomics. 2010 Aug;53(8):1033-8. doi: 10.1080/00140139.2010.494458.

PMID:
20658397
36.

Molecular structure of tail tendon fibers in TIEG1 knockout mice using synchrotron diffraction technology.

Gumez L, Bensamoun SF, Doucet J, Haddad O, Hawse JR, Subramaniam M, Spelsberg TC, Pichon C.

J Appl Physiol (1985). 2010 Jun;108(6):1706-10. doi: 10.1152/japplphysiol.00356.2010. Epub 2010 Apr 8.

37.

Tumor cell/endothelial cell tight contact upregulates endothelial adhesion molecule expression mediated by NFkappaB: differential role of the shear stress.

Haddad O, Chotard-Ghodsnia R, Verdier C, Duperray A.

Exp Cell Res. 2010 Feb 15;316(4):615-26. doi: 10.1016/j.yexcr.2009.11.015. Epub 2009 Nov 26.

38.

Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.

Friand V, Haddad O, Papy-Garcia D, Hlawaty H, Vassy R, Hamma-Kourbali Y, Perret GY, Courty J, Baleux F, Oudar O, Gattegno L, Sutton A, Charnaux N.

Glycobiology. 2009 Dec;19(12):1511-24. doi: 10.1093/glycob/cwp130. Epub 2009 Aug 28.

PMID:
19717493
39.

TIEG1-NULL OSTEOCYTES DISPLAY DEFECTS IN THEIR MORPHOLOGY, DENSITY AND SURROUNDING BONE MATRIX.

Haddad O, Hawse JR, Subramaniam M, Spelsberg TC, Bensamoun SF.

J Musculoskelet Res. 2009 Sep;12(3):127-136.

40.

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO, Gattegno L, Oudar O, Sutton A, Charnaux N.

Int J Cancer. 2010 Mar 1;126(5):1095-108. doi: 10.1002/ijc.24800.

41.

Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.

Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A.

Biochim Biophys Acta. 2009 Oct;1790(10):1314-26. doi: 10.1016/j.bbagen.2009.07.015. Epub 2009 Jul 24.

PMID:
19632304
42.

Cellular interferon-gamma based assay for diagnosis of pulmonary tuberculosis.

Fathy MM, Asaad A, Mansour M, El-Said H, El-Haddad OK.

Egypt J Immunol. 2007;14(1):33-41.

PMID:
18689279
43.

Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder.

Gonzalez S, Aubert S, Kerdraon O, Haddad O, Fantoni JC, Biserte J, Leroy X.

Am J Clin Pathol. 2008 Feb;129(2):232-7. doi: 10.1309/2TY6GTV1GQ6B5ARM.

PMID:
18208803
44.

Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.

Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, Vassy R, Haddad O, Sainte-Catherine O, Kraemer M, Saffar L, Perret GY, Courty J, Gattegno L, Charnaux N.

Mol Cancer Ther. 2007 Nov;6(11):2948-58.

45.

Morphological analysis of tumor cell/endothelial cell interactions under shear flow.

Chotard-Ghodsnia R, Haddad O, Leyrat A, Drochon A, Verdier C, Duperray A.

J Biomech. 2007;40(2):335-44. Epub 2006 Feb 23.

46.

[Infertility and testicular tumour based on a series of 25 patients].

Haddad O, Leroy X, Lemaitre L, Biserte J, Rigot JM.

Prog Urol. 2005 Dec;15(6):1096-100. French.

PMID:
16429659
47.

Transvaginal sonographic evaluation of cervix length after cervical conization.

Mazouni C, Bretelle F, Blanc K, Heckenroth H, Haddad O, Agostini A, Cravello L, Blanc B, Gamerre M.

J Ultrasound Med. 2005 Nov;24(11):1483-6.

PMID:
16239649
48.

Conservative treatment of cervical intraepithelial neoplasia using a cold-knife section technique.

Mazouni C, Porcu G, Haddad O, Dalès JP, Taranger-Charpin C, Piana L, Bonnier P.

Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):86-93.

PMID:
15950367
49.

Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.

Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, Allasia C, Bonnier P, Charpin C.

Int J Cancer. 2005 Sep 20;116(5):734-9.

50.

Diagnosis and management of adenocarcinoma of the ampulla of Vater during pregnancy.

Haddad O, Porcu-Buisson G, Sakr R, Guidicelli B, Letreut YP, Gamerre M.

Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):246-9.

PMID:
15808389

Supplemental Content

Loading ...
Support Center